Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
November 23, 2021
Patent Application Number
16078760
Date Filed
February 24, 2017
Patent Primary Examiner
Patent abstract
Three proteins, BCL-G (BCL2L14), CMPK2, and LAMP3, were discovered to independently restrict HIV-1 replication both in-vivo and in-vitro. Methods are described wherein subjects are given an effective amount of a pharmaceutical composition comprising a protein selected from the group consisting of BCL-G, CMPK2, LAMP3, functional parts thereof, recombinant proteins thereof, and combinations thereof, for the purpose of treating or preventing HIV.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
